UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - ACCELERATE DIAGNOSTICS INC ownership

ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 121 filers reported holding ACCELERATE DIAGNOSTICS INC in Q2 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.5%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of ACCELERATE DIAGNOSTICS INC
ValueSharesWeighting
Q1 2022$48,335,000
-72.4%
33,5660.0%0.00%
Q4 2021$175,214,000
-6.7%
33,566
+4.2%
0.00%
Q3 2021$187,737,000
-26.9%
32,202
+1.0%
0.00%
Q2 2021$256,921,000
-0.2%
31,876
+3.0%
0.00%
Q1 2021$257,512,000
+9.8%
30,9510.0%0.00%
Q4 2020$234,609,000
-28.9%
30,9510.0%0.00%
Q3 2020$329,938,000
+45.1%
30,951
+106.3%
0.00%
Q2 2020$227,400,000
+7.3%
15,000
-41.0%
0.00%
Q1 2020$211,915,000
-53.8%
25,440
-6.3%
0.00%
Q4 2019$458,920,000
-9.2%
27,155
-0.2%
0.00%
Q3 2019$505,457,000
+40.7%
27,219
+73.4%
0.00%
Q2 2019$359,216,000
+8.8%
15,7000.0%0.00%
Q1 2019$330,014,000
+82.8%
15,7000.0%0.00%
Q4 2018$180,550,000
-49.9%
15,7000.0%0.00%
Q3 2018$360,315,000
+2.9%
15,7000.0%0.00%
Q2 2018$350,110,000
+72.2%
15,700
+76.4%
0.00%
Q1 2018$203,365,000
-12.8%
8,9000.0%0.00%
Q4 2017$233,180,000
-4.2%
8,9000.0%0.00%
Q2 2017$243,415,000
+52135.0%
8,900
-48.0%
0.00%
-100.0%
Q3 2016$466,000
+89.4%
17,1000.0%0.00%
Q2 2016$246,0000.0%17,1000.0%0.00%
Q1 2016$246,000
-33.0%
17,1000.0%0.00%
Q4 2015$367,000
+32.5%
17,1000.0%0.00%
Q3 2015$277,00017,1000.00%
Other shareholders
ACCELERATE DIAGNOSTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Birchview Capital, LP 2,183,795$36,906,00026.83%
ORACLE INVESTMENT MANAGEMENT INC 4,213,152$71,202,00013.37%
Selkirk Management LLC 697,610$11,790,0003.21%
GRIFFIN ASSET MANAGEMENT, INC. 994,657$16,810,0002.36%
Chicago Capital, LLC 1,314,093$22,208,0001.36%
OAKTOP CAPITAL MANAGEMENT II, L.P. 155,000$2,620,0000.69%
CHARTIST INC /CA/ 64,765$1,094,529,0000.67%
Cannell & Co. 1,095,439$18,513,0000.66%
Trellus Management Company, LLC 22,500$380,0000.64%
Belpointe Asset Management LLC 271,514$4,589,0000.58%
View complete list of ACCELERATE DIAGNOSTICS INC shareholders